Showing entries for:
We’re thrilled to share exciting news from METAvivor: we have received 195 Letters of Intent (LOIs) for our 2025 metastatic breast cancer (MBC) research grant cycle — nearly double the number we typically receive in a given year.
Gloria Echeverria, PhD, a former METAvivor Research Award grantee, shares her thoughts on the current challenges researchers are facing due to funding cuts.
METAvivor Research and Support announces 12 new grant awards to research investigators for metastatic breast cancer research totaling $3.75 million.
